STOCK TITAN

Steris Plc - STE STOCK NEWS

Welcome to our dedicated news page for Steris Plc (Ticker: STE), a resource for investors and traders seeking the latest updates and insights on Steris Plc.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Steris Plc's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Steris Plc's position in the market.

Rhea-AI Summary
STERIS plc (NYSE: STE) will host a conference call on May 9, 2024, to discuss its fiscal 2024 fourth quarter and full year financial results. The call will be accessible online and via phone. A press release with financial details will be issued on May 8, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
-
Rhea-AI Summary
Peak Rock Capital's affiliate acquires HuFriedyGroup from STERIS plc, a leading dental industry manufacturer, aiming for new product innovation and organic growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.4%
Tags
-
Rhea-AI Summary
STERIS plc (NYSE: STE) announced the divestiture of its Dental segment to Peak Rock Capital for $787.5 million, with potential additional earnings of up to $12.5 million. The transaction aims to streamline focus on core markets, with proceeds intended to repay debt. The Dental segment contributed $407 million in revenue and $86 million in operating income in the last twelve months. The deal is expected to close in STERIS's first quarter of fiscal 2025.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.4%
Tags
none
Rhea-AI Summary
STERIS plc (STE) reported a 15% increase in revenue for the third quarter of fiscal 2024, reaching $1.40 billion. The company also saw a net income of $140.7 million or $1.42 per diluted share, a significant increase from the previous year. The Healthcare segment grew 19% in revenue, while the Life Sciences segment saw a 21% increase. The company also updated its fiscal 2024 outlook, expecting a 10-11% increase in revenue and adjusted earnings per diluted share in the range of $8.60 to $8.70.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.48%
Tags
-
Rhea-AI Summary
STERIS plc (STE) has declared a quarterly interim dividend of $0.52 per share, payable on March 22, 2024, to shareholders of record on February 23, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.36%
Tags
dividends
-
Rhea-AI Summary
STERIS plc (STE) will host a conference call to discuss its fiscal 2024 third quarter financial results on February 8, 2024. The call can be accessed live at www.steris-ir.com or via phone. A press release detailing financial results will be issued after the U.S. market closes on February 7, 2024. A replay of the call will be available for those unable to listen live.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.89%
Tags
conferences earnings
Rhea-AI Summary
STERIS plc (NYSE: STE) Reports 12% Revenue Growth in Q2 2024, Anticipates 9-10% Growth for Fiscal 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.46%
Tags
-
Rhea-AI Summary
STERIS plc (NYSE: STE) has announced that it will distribute a quarterly interim dividend of $0.52 per share. The dividend will be payable on December 21, 2023, to shareholders of record on November 21, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.41%
Tags
dividends
-
Rhea-AI Summary
STERIS plc to host conference call to discuss fiscal 2024 second quarter financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.94%
Tags
conferences earnings
Rhea-AI Summary
STERIS plc to participate in Morgan Stanley Healthcare Conference on September 13, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.04%
Tags
conferences
Steris Plc

NYSE:STE

STE Rankings

STE Stock Data

20.16B
98.45M
0.27%
97.96%
2.71%
Surgical Appliance and Supplies Manufacturing
Manufacturing
Link
United Kingdom
Leicester

About STE

steris is a leading provider of infection prevention and procedural surgical products and services, focused primarily on healthcare, pharmaceutical, research and medical device customers. our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. while the corporation was founded as innovative medical technologies in 1985 and renamed steris in 1987, our history dates back to 1894 with the founding of american sterilizer company, a long-time, global leading innovator of sterilization products. today, through a series of strategic acquisitions and continual innovation of new products, steris holds one of the broadest portfolios of products in the industry. it stands at the forefront of efforts to prevent infection and contamination in healthcare, pharmaceutical and medical device environments.